Compounds > epirubicin
Page last updated: 2024-08-23

epirubicin and B16 Melanoma

epirubicin has been researched along with B16 Melanoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deng, Y; Hu, L; Liu, X; Liu, Y; Luo, X; Peng, B; Song, Y; Zhang, T; Zhou, S1
Bekeschus, S; Bodnar, Y; Gandhirajan, RK; Pasqual-Melo, G; Sagwal, SK1
Chen, J; Chen, X; Li, N; Liu, Y; Sun, Q; Wang, B1
Cai, Y; Chen, H; Gao, F; Li, L; Li, X; Liu, L; Wang, Y; Yang, W; Zhang, H; Zhang, Q; Zhou, J; Zhou, Z1
Cichocka, K; Górecki, P; Kuśnierczyk, H; Radzikowski, C1

Other Studies

5 other study(ies) available for epirubicin and B16 Melanoma

ArticleYear
Polysialic acid-polyethylene glycol conjugate-modified liposomes as a targeted drug delivery system for epirubicin to enhance anticancer efficiency.
    Drug delivery and translational research, 2018, Volume: 8, Issue:3

    Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Drug Liberation; Drug Stability; Epirubicin; Liposomes; Male; Melanoma, Experimental; Mice, Inbred C57BL; Phosphatidylethanolamines; Polyethylene Glycols; Rats, Wistar; Sialic Acids; Tumor Burden

2018
Combination of chemotherapy and physical plasma elicits melanoma cell death via upregulation of SLC22A16.
    Cell death & disease, 2018, 12-05, Volume: 9, Issue:12

    Topics: Animals; Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Cell Death; Cell Line, Tumor; Chemokine CXCL10; Coculture Techniques; Combined Modality Therapy; Doxorubicin; Epirubicin; Epithelial Cells; Gene Expression Regulation, Neoplastic; Histones; Humans; Melanoma, Experimental; Mice; Organic Cation Transport Proteins; Oxaliplatin; Plasma Gases; THP-1 Cells; Vorinostat

2018
CYR61 suppresses growth of human malignant melanoma.
    Oncology reports, 2016, Volume: 36, Issue:5

    Topics: Animals; Antibodies, Monoclonal; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cysteine-Rich Protein 61; Epirubicin; Gene Expression Regulation, Neoplastic; Humans; Interferon-alpha; Melanoma; Melanoma, Experimental; Mice; Neoplasm Metastasis; Skin Neoplasms

2016
Deoxycholic acid modified-carboxymethyl curdlan conjugate as a novel carrier of epirubicin: in vitro and in vivo studies.
    International journal of pharmaceutics, 2010, Jun-15, Volume: 392, Issue:1-2

    Topics: Animals; Antibiotics, Antineoplastic; beta-Glucans; Cell Line, Tumor; Cell Survival; Deoxycholic Acid; Drug Carriers; Drug Compounding; Epirubicin; Flow Cytometry; Humans; Hydrogen-Ion Concentration; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Molecular Structure; Nanoparticles; Particle Size; Solubility; Tissue Distribution; Xenograft Model Antitumor Assays

2010
Comparative evaluation of toxicity and antitumor activity of original and reproduced anthracycline drugs.
    Archivum immunologiae et therapiae experimentalis, 1994, Volume: 42, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Chemistry, Pharmaceutical; Doxorubicin; Drug Screening Assays, Antitumor; Epirubicin; Female; Lethal Dose 50; Leukemia P388; Male; Melanoma, Experimental; Mice; Mice, Inbred Strains; Neoplasm Transplantation

1994